SCHEMBL21844896

SCHEMBL21844896

COCCN(C)CCc1cccc(C(=O)Nc2ccc(C)c(Cl)c2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.49
▸ MEN1 O00255 4/20 0.48
▸ KMT2A Q03164 4/20 0.48
▸ POLB P06746 1/20 0.48
▸ HPGD P15428 2/20 0.47
▸ KDR P35968 2/20 0.46
▸ MAPK14 Q16539 1/20 0.45
▸ NPC1 O15118 4/20 0.44
▸ RAB9A P51151 4/20 0.44
▸ ROCK2 O75116 3/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ CASP3 P42574 2/20 0.44
▸ SENP7 Q9BQF6 2/20 0.44
▸ SENP6 Q9GZR1 2/20 0.44
▸ MAPT P10636 4/20 0.44
▸ LMNA P02545 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21844850 0.82 KDR (0.43) MEN1KMT2AKDRMAPK14NPC1
SCHEMBL21844897 0.80 NPC1 (0.51) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL20083999 0.80 KDR (0.43) MEN1KMT2AKDRROCK2LMNA
SCHEMBL21844848 0.80 PARP1 (0.49) PARP1MEN1KMT2APOLBHPGD
SCHEMBL20083950 0.74 KDR (0.46) MEN1KMT2AKDRROCK2LMNA
SCHEMBL21844862 0.74 MEN1 (0.59) MEN1KMT2APOLBRAB9ASMN1; SMN2
SCHEMBL21844847 0.74 TMEM97 (0.52) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL4248100 0.73 KCNK3 (0.69) MEN1KMT2APOLBHPGDNPC1
SCHEMBL19157150 0.73 PARP1 (0.51) PARP1MEN1KMT2APOLBNPC1
SCHEMBL6476472 0.73 MAPK14 (0.60) HPGDMAPK14MAPTALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312160-B1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS INC (US) 2020-03-18 — — EP disclosed
Send feedback